XML 24 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (165,297) $ (120,088) $ (31,781)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 290 357 462
Stock-based compensation 8,452 7,997 4,743
Change in fair value of warrants     (11,723)
Common stock issued in exchange for license agreement   67,285  
Preferred stock issued in exchange for 2016 ECP amendment 118,936    
Change in fair value of derivative liabilities 124    
Issuance of common stock in a license agreement 87    
(Increase) decrease in:      
Receivables 425 (301)  
Prepaid expenses and other current assets (12,452) (10,214) 809
Other noncurrent assets   (3) 37
Increase (decrease) in:      
Accounts payable (1,852) 4 1,582
Accrued expenses 203 1,724 827
Deferred revenue (6,861) 53,418 (1,373)
Deferred rent (380) (189) (213)
Other noncurrent liabilities     (20)
Net cash used in operating activities (58,325) (10) (36,650)
Cash flows from investing activities:      
Purchases of property and equipment (551) (412) (193)
Net cash used in investing activities (551) (412) (193)
Cash flows from financing activities:      
Proceeds from exercise of stock options 714 4,568 1,386
Payments to employees for repurchase of restricted common stock (1,500) (518) (544)
Proceeds from exercise of warrants     10,600
Repurchase of common stock (2) (34)  
Proceeds from issuance of common stock, net   94,320  
Net cash provided by (used in) financing activities (788) 98,336 11,442
Net decrease in cash and cash equivalents (59,664) 97,914 (25,401)
Cash and cash equivalents, beginning of period 140,717 42,803 68,204
Cash and cash equivalents, end of period 81,053 140,717 42,803
Supplementary disclosure of cash flow information:      
Cash paid for interest 0 0 0
Cash paid for income taxes 0 0 0
Supplementary disclosure of noncash investing and financing activities:      
Exercise of equity-classified warrants to common shares     692
Exercise of liability-classified warrants to common shares     $ 54
Common Stock      
Supplementary disclosure of noncash investing and financing activities:      
Issuance of stock   $ 67,285  
Series 1 Preferred Stock      
Supplementary disclosure of noncash investing and financing activities:      
Issuance of stock 119,045    
Payment of dividends in preferred stock $ 7,123